The samples were embedded in resin, and ultrathin sections were cut and stained with uranyl acetate and lead citrate

The samples were embedded in resin, and ultrathin sections were cut and stained with uranyl acetate and lead citrate. resulted in increases in the size and reduction in the number of cardiomyocytes in the heart. Copper repletion led to regression in the size of hypertrophic cardiomyocytes and normalization of the total quantity of cardiomyocytes. Although a direct reduction in the cell size would be significantly responsible for the regression of heart hypertrophy, some hypertrophied cardiomyocytes upon copper repletion reentered the cell cycle as determined by Ki-67 staining in the cardiomyocyte-specific -sarcomeric actin stained cells and underwent division as determined by a mitosis-specific marker phosphor-histone H3. Quantitative analysis indicated that this replication of hypertrophic cardiomyocytes made a contribution about 1/3 to the total mitosis of the regenerated myocardium. This study suggests that a direct reduction in the size of some hypertrophied cardiomyocytes and a replication of other hypertrophied cardiomyocytes with reduced size make a significant contribution to the regression of copper deficient heart hypertrophy, leading to normalization of the size and the number of cardiomyocytes in the heart. Keywords:Cell cycle, copper, hypertrophy, mitosis, myocardial regeneration, regression == Introduction == Copper (Cu) is an essential trace element and dietary Cu restriction prospects to cardiac hypertrophy (1). Cu deficient heart hypertrophy in mouse and rat models has characteristic structural, biochemical, and signaling alterations resembling those induced by pressure overload (1), and transits to heart failure (2). We have recently observed that dietary Cu repletion results in a rapid regression of the hypertrophy and a complete functional recovery (3). The regression of heart hypertrophy and functional recovery indicate a cytokinetic switch in the hypertrophic cardiomyocytes. Possible mechanisms underlying the switch include apoptosis leading to a clean up of the hypertrophic cardiomyocytes, a reduction in cellular volume making the hypertrophic myocytes smaller by an unknown mechanism, or mitosis of the hypertrophic cardiomyocytes with reduced cell size leading to myocardial regeneration. Apoptosis of cardiomyocytes in the failing heart is a major cellular event involved in the pathogenesis (4). Our early studies have shown that dietary Cu deficiency causes myocardial apoptosis (5), which would be highly responsible for the transition from cardiac hypertrophy to heart failure. Defective myocardial function is usually associated with the loss of cardiomyocytes due to apoptosis. In the regression induced by Cu repletion in Cu deficiency-induced hypertrophic LY2835219 (abemaciclib) hearts, the depressed function was completely recovered (3) and myocardial structures were normalized as examined by both light and electron microscopes (3). Therefore, it is unlikely that apoptosis can be responsible for the regression of heart hypertrophy induced by Cu repletion. Heart hypertrophy developed under physiological stimulations such LY2835219 (abemaciclib) as exercise-induced myocardial growth is usually reversible (6), although molecular mechanisms involved in the regression of physiological heart hypertrophy have not been fully comprehended. At the cellular level, the size of hypertrophied cardiomyocytes has to become LW-1 antibody smaller or normalized in order for the regression of heart hypertrophy to occur. This process would be accomplished by a direct reduction in the size of the hypertrophied cardiomyocytes. Under pathological condition, heart hypertrophy can also be reversed under different conditions in mice (7,8). This LY2835219 (abemaciclib) regression, however, would be more complicated than a simple reduction in the size of hypertrophied cardiomyocytes under LY2835219 (abemaciclib) physiological conditions. The functional recovery of the failing heart would demand myocardial regeneration, which requires repletion of the lost cardiomyocytes during the transition from cardiac hypertrophy to heart failure. Myocardial regeneration through mitosis of the hypertrophic cardiomyocytes with reduced cell size potentially is an attractive mechanism for regression of heart hypertrophy and recovery of myocardial function observed in the Cu deficient hearts. Even though view of the adult mammalian heart as a terminally differentiated organ without regenerative capacity remains dominant (9), recently documented evidence difficulties this belief. Several studies have shown the.